Investigating Deep Brain Stimulation of the Habenula: A Review of Clinical Studies
Mickey E. Abraham,Vera Ong,Julian Gendreau,Nolan J. Brown,Elliot H. Choi,Nathan A. Shlobin,Chen Yi Yang,Shane Shahrestani,Shane Shahrestani,Alexander S. Himstead,Donald K. Detchou,Neal Patel,Justin Gold,Ronald Sahyouni,Luis D. Diaz-Aguilar,Sharona Ben-Haim
DOI: https://doi.org/10.1016/j.neurom.2022.05.005
2023-02-01
Abstract:ObjectivesThe aim of this study was to examine the current scientific literature on deep brain stimulation (DBS) targeting the habenula for the treatment of neuropsychiatric disorders including schizophrenia, major depressive disorder, and obsessive-compulsive disorder (OCD).Materials and MethodsTwo authors performed independent data base searches using the PubMed, Cochrane, PsycINFO, and Web of Science search engines. The data bases were searched for the query (“deep brain stimulation” and “habenula”). The inclusion criteria involved screening for human clinical trials written in English and published from 2007 to 2020. From the eligible studies, data were collected on the mean age, sex, number of patients included, and disorder treated. Patient outcomes of each study were summarized.ResultsThe search yielded six studies, which included 11 patients in the final analysis. Treated conditions included refractory depression, bipolar disorder, OCD, schizophrenia, and major depressive disorder. Patients with bipolar disorder unmedicated for at least two months had smaller habenula volumes than healthy controls. High-frequency stimulation of the lateral habenula attenuated the rise of serotonin in the dorsal raphe nucleus for treating depression. Bilateral habenula DBS and patient OCD symptoms were reduced and maintained at one-year follow up. Low- and high-frequency stimulation DBS can simulate input paths to the lateral habenula to treat addiction, including cocaine addiction. More data are needed to draw conclusions as to the impact of DBS for schizophrenia and obesity.ConclusionsThe habenula is a novel target that could aid in reducing neuropsychiatric symptoms and should be considered in circuit-specific investigation of neuromodulation for psychiatric disorders. More information needs to be gathered and assessed before this treatment is fully approved for treatment of neuropsychiatric conditions.
medicine, research & experimental,clinical neurology